|
Embryonal Carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
Neurogenesis Using P19 Embryonal Carcinoma Cells.
|
31081818 |
2019 |
|
Embryonal Carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
In this study, using Western blotting and RT-qPCR techniques and the fluorescent splicing reporters, we examined the detailed expression patterns of l- and s-afadin isoforms across various tissues and cell types, including rat organs at developmental stages, primary cultured neuronal and non-neuronal cells prepared from the developing rat brain, and in neurons in vitro generated from P19 embryonal carcinoma (EC) cells.
|
30572094 |
2019 |
|
Embryonal Carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Like BOC, SGTb is highly expressed in brain and P19 embryonal carcinoma (EC) cells differentiated into neuronal cells.
|
30639199 |
2019 |
|
Embryonal Carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
Murine P19 embryonal carcinoma (EC) cells are convenient to differentiate into all germ layer derivatives.
|
28013042 |
2017 |
|
Embryonal Carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
Therefore, we examined whether allelic pairing of Oct4 loci also occurs during differentiation of F9 and P19 ECCs.
|
28967672 |
2017 |
|
Embryonal Carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
Retinoic acid signaling has been thoroughly interrogated in ECCs, especially in the F9 and P19 murine cell models, and while we have touched on this aspect, this review purposely highlights how some key transcription factors regulate pluripotency and cell stemness prior to this signaling.
|
28373885 |
2017 |
|
Embryonal Carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
Here, we demonstrate that BOC and ABL are induced in P19 embryonal carcinoma (EC) cells and cortical neural progenitor cells (NPCs) during neuronal differentiation.
|
27871935 |
2017 |
|
Embryonal Carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
The P19 EC cells differentiate to form neurons but the ability of the neurites to extend and make contacts with neighbouring neurites is compromised when treated with the hANG-ALS variants.
|
17916583 |
2008 |
|
Embryonal Carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
In the present study, we used antisera that specifically recognized the active forms of caspase-8, -3, and -9 but not their proforms, and showed that only caspase-8 and -3 were activated during the generation of polyQ72 aggregates in P19 EC cell nuclei.
|
11070498 |
2000 |
|
Embryonal Carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
In exponentially growing P19 embryonal carcinoma (EC) cells, WT1 mRNA and proteins were undetectable.
|
9040935 |
1997 |
|
Embryonal Carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
Forced expression of mouse p130 induced growth suppression of P19 EC cells and Western analysis of transfected P19 cells suggested the cloned cDNA encodes the full-length p130 protein.
|
8622859 |
1996 |
|
Embryonal Carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
Addition of cell extract from undifferentiated P19 embryonal carcinoma (EC) cells preferentially stimulated translation of an IGF-II 5' UTR RNA construct.
|
7980416 |
1994 |
|
Embryonal Carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
These studies demonstrate that P19 EC cell differentiation can be divided into LIF sensitive and insensitive pathways which correlate with differentiation of endodermal/mesodermal and neuro-ectodermal cell types, respectively.
|
1322335 |
1992 |
|
Embryonal Carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Hox-4.2 promoter activity was assayed by transient expression assays in P19 embryonal carcinoma (EC) cells.
|
1356763 |
1992 |